Transasia Bio-Medicals, as part of its global expansion plan, has acquired two US based companies – Drew Scientific and JAS Diagnostics Inc from Escalon Medical. The acquisition was done through Transasia’s subsidiary, Erba Diagnostics USA. It has acquired the entire business assets including plant and intellectual assets, which will become a direct wholly-owned subsidiary of Erba Diagnostics.
Transasia Group’s acquisition of Drew Scientific marks its entry in the fast growing segment of diabetes management worldwide. It would benefit with the capabilities to offer proprietary liquid chromatography-based glycated haemoglobin analysers and reagents to the laboratories worldwide.
JAS Diagnostics Inc is a manufacturer of clinical chemistry reagents. It supplies chemistry reagents that it has developed indigenously. It offers solutions in different formats of systems packs, liquid reagents and powder reagents.
Suresh Vazirani, Chairman and Managing Director, Transasia Bio-Medicals stated, “The acquisition was a natural consequence of its focus on the challenges posed by the vast and fast growing diabetes monitoring segment.” He further added, “It is also to address the lack of quality solutions and supply options in India specifically and worldwide in the monitoring of long term glycemic control.”
Transasia is already a leading player in the field of autoimmune and Infectious diseases testing in North America with proprietary Mago platform and immunosimplicity range of immunoassays. With this acquisition, Transasia will also foray in the physician/ doctor’s office segment of clinical chemistry, haematology instruments and reagents in North America.
The company also has plans to expand its markets for existing range of diabetes management, haematology and clinical chemistry in the rest of the world, leveraging its direct presence in US, Italy, Eastern Europe, Russian Federation, Turkey and its distribution partners in 90 countries worldwide. Transasia plans to offer range of automated solutions in clinical chemistry in the North American market.
EH News Bureau